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June 20101588 Abstractsproposed treatment option (11/13; 85% and 19/22; 86%), the alternative
treatment option was mentioned only occasionally (4/13; 31% and 14/22;
64%).
Conclusions: Patients with an abdominal aneurysm are informed incon-
sistently about their disorder and treatment options. Information is often less
than that legally required. This may hinder shared decision making.
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Objectives: This article describes the long-term outcome of surgical
treatment in children with renovascular hypertension (RVH) over a 40-year
period.
Design: Retrospective study.
Materials and methods: Twenty-five consecutive patients, aged 5–21
years, underwent renal artery (RA) repair from 1967 to 1995. The disease
consisted of fibromuscular dysplasia in 17 patients, Takayasu’s arteritis in 7
and neurofibromatosis type 1 in one patient.
Results: Twenty-nine RAs were repaired. Primary procedures included
aortorenal bypass (ARB) with prosthesis in 10 RAs, autologous vein in five
or internal iliac artery in four as conduits, direct reimplantation (DR) in four
and nephrectomy in two RAs. Immediate graft failure occurred in three
patients despite no peri-operative deaths. After a mean follow-up of 24.4
years, seven patients required secondary nephrectomy. Autologous ARB or
DR showed better RA patency and fewer chances for secondary nephrec-
tomy than prosthetic ARB. Hypertension was cured or improved in 21
patients. The overall cumulative survival rate at 20 years was 84%. All five
deaths, observed a mean of 12.6 years after the initial operation, were
attributed to cardiovascular events.
Conclusions: Surgical treatment, especially autologous ARB or DR,
seems to provide durable results for paediatric RVH. Long-term observation
and control of hypertension is mandatory.
PTFE Bypass to Below-knee Arteries: Distal Vein Collar or Not? A
Prospective Randomised Multicentre StudyReaders can access EJVES articles at http://intl.eBackground: Patency and limb salvage after synthetic bypass to the
arteries below-knee are inferior to that which can be achieved with autolo-
gous vein. Use of a vein collar at the distal anastomosis has been suggested to
improve patency and limb salvage, a problem that is analysed in this
randomised clinical study.
Methods: Patients with critical limb ischaemia undergoing polytetra-
fluoroethylene (PTFE) bypass to below-knee arteries were randomly either
assigned a vein collar or not in two groups – bypass to the popliteal artery
below-knee (femoro-popliteal below-knee (FemPopBK)) and more distal
bypass (femoro-distal bypass (FemDist)). Follow-up was scheduled until
amputation, death or at most 5 years, whichever event occurred first.
Results: In the FemPopBK and in the FemDist groups, 115/202 and
72/150were randomised to have a vein collar, respectively. Information was
available for 345 of 352 randomised patients (98%).
At 3 years, primary patency was 26% (95% confidence interval (CI)
18–38) with a vein collar and 43 (33–58) without a vein collar for femoro-
popliteal bypass and 20 (11–38), and 17 (9–33) for femoro-distal bypass,
respectively. The corresponding figures for limb salvage were 64 (54–75)
and 61 (50–74) for femoro-popliteal bypass, and 59 (46–76) and 44
(32–61) for femoro-distal bypass with and without a vein collar, respec-
tively. Log-rank-test for the whole Kaplan–Meier life table curve showed no
statistically significant differences with or without vein collar primary pa-
tency: p  0.0853, p  0.228; secondary patency: p  0.317, p  0.280;
limb salvage: p  0.757, p  0.187 for FemPopBK and FemDist, respec-
tively. The use of a vein collar did not influence patency or limb salvage.
Conclusion: This study failed to show any benefit for vein collar with
PTFE bypass to a below-knee artery.
Endovascular Management of Critical Limb Ischemia
Blevins W.A.Jr., Schneider P.A. Eur J Vasc Endovasc Surg 2010;39:755-60.
Endovascular management of critical limb ischemia has advanced sig-
nificantly in the recent past, especially the ability to treat tibial artery lesions
with reasonable results. The indications, results, and technical aspects or
endovascular management of CLI is reviewed herein. An algorithm forSCAMICOS. Eur J Vasc Endovasc Surg 2010;39:746-53.
clinical management of CLI in patients with tibial occlusive disease is also
presented.lsevierhealth.com/journals/ejvs/default.cfm
